Provectus Biopharmaceuticals Inc (NYSE MKT LLC:PVCT)

0.815
Delayed Data
As of Mar 30
 -0.02 / -2.40%
Today’s Change
0.30
Today|||52-Week Range
3.75
+1.87%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization680.0K678.5K677.3K677.5K
 
 
 
 
 
 
Operating ExpensesGross Income-680.0K-678.5K-677.3K-677.5K
 
 
 
 
 
General Expenses20.0M20.8M13.7M12.4M
 
 
 
 
 
Research And Development8.4M8.8M5.0M3.6M
 
 
 
 
 
Total Operating Expenses20.7M21.4M14.3M13.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-20.7M-21.4M-14.3M-13.0M
 
 
 
 
 
Extraordinary Credit2.1M2.0M1.8M0.00
 
 
 
 
Extraordinary Charge0.000.000.00-14.7M
 
 
Other Expenses1.2K1.5K0.000.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-18.6M-19.4M-12.6M-27.7M
 
 
 
 
 
Preferred Dividend-10.4M-247.0K-183.2K-1.2M
 
 
 
 
 
Net Income-18.6M-19.4M-12.6M-27.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS78.8M105.7M113.0M132.0M
 
 
 
 
 
Shares To Calculate EPS Diluted78.8M105.7M113.0M132.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.37-$0.19-$0.11-$0.22
 
 
 
 
 
EPS Diluted-$0.37-$0.19-$0.11-$0.22
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account